KATRD
LOGIN
- KATRD 2025 International Conference
-
October 29(Wed)-31(Fri), 2025 Lotte Hotel World, Seoul, Kore
- Program
Program in Detail
- ALL
-
- ALL
- Plenary Session
- ATS-KATRD Joint Symposium
- JRS-KATRD Joint Symposium
- MTS-KATRD Joint Symposium
- Airway
- Bronchoscopy
- Asthma
- Critical Care Medicine
- Cough
- COPD
- Thoracic Ultrasound
- Environmental Lung Disease
- ILD
- Lung Cancer
- Pulmonary Rehabilitation
- Pulmonary Vascular Disease
- Tuberculosis
- Editors Desk
- Infection
- 한국어교육세션
- 일선진료의를 위한 결핵 강좌
- 연구비발표
- Luncheon Symposium
- Satellite Symposium
- Ceremony
- Oral
Panelists are identified by asterisk(*) marks.
Wednesday, October 29 |
||
|
International Network Meeting 5 Lung Cancer - Defining the Optimal Window for CIO Therapy in Resectable NSCLC |
Wednesday, October 29,
15:30-17:00 Room 3 CRYSTAL 3 (3F) |
|
|---|---|---|
| Chair | Young-Chul Kim (Chonnam National University, Korea) | |
| 15:30-16:00 |
Considerations of the Patient Selection for Perioperative CIO Therapy in NSCLC
Chao-Hua Chiu (Taipei Medical University, Taiwan)
|
|
| 16:00-16:30 |
Refining the Timing: Neoadjuvant vs. Perioperative CIO Therapy
Terufumi Kato (Tokyo Metropolitan Komagome Hospital, Japan)
|
|
| 16:30-17:00 |
Surgical Perspectives for Perioperative CIO Therapy
Hong Kwan Kim (Sungkyunkwan University, Korea)
|
|
Thursday, October 30 |
||
|
Luncheon Symposium 3 Lung Cancer  |
Thursday, October 30,
12:00-12:30 Room 3 CRYSTAL 3 (3F) |
|
| Chair | In-Jae Oh (Chonnam National University, Korea) | |
| 12:00-12:30 |
The LASER Effect : Lazertinib's Rise as a New SoC in EGFR m+ NSCLC 1st Line Treatment
Mi-Hyun Kim (Pusan National University, Korea)
|
|
|
Symposium 09 Lung Cancer 1 - Rare AGAs in Advanced NSCLC: Evolving Therapeutic Approaches |
Thursday, October 30,
15:30-17:00 Room 3 CRYSTAL 3 (3F) |
|
| Chair | Sung Yong Lee (Korea University, Korea) | |
| 15:30-16:00 |
Targeting METex14 in NSCLC: Clinical Advances and Unmet Needs
Terufumi Kato (Tokyo Metropolitan Komagome Hospital, Japan)
|
|
| 16:00-16:30 |
New Frontiers in KRAS-Mutant NSCLC: Therapeutic Strategies and Resistance
Jung Seop Eom (Pusan National University, Korea)
|
|
| 16:30-17:00 |
Redefining First-Line Standards with Unprecedented Survival in ALK-positive NSCLC
Cheol-Kyu Park (Chonnam National University, Korea)
|
|
Friday, October 31 |
||
|
Meet the Expert 5 Lung Cancer |
Friday, October 31,
07:30-08:15 Room 6 RUBY (3F) |
|
| Chair | Tae-Won Jang (Kosin University, Korea) | |
| 07:30-08:15 |
Beyond Chemoradiation Therapy: Harnessing Immunotherapy to Conquer LA-NSCLC and SCLC-LS
James Yang (National Taiwan University Hospital, Taiwan)
|
|
|
Symposium 12 Lung Cancer 2 - Lung Cancer Screening and Diagnosis |
Friday, October 31,
10:20-11:50 Room 3 CRYSTAL 3 (3F) |
|
| Chair | Sei-Hoon Yang (Wonkwang University, Korea) | |
| 10:20-10:50 |
Pearls and Pitfalls in Lung Cancer Screening
Yeon Wook Kim (Seoul National University, Korea)
|
|
| 10:50-11:20 |
The Evolving Role of Liquid Biopsy in Lung Cancer Screening and Diagnosis
In Ae Kim (Konkuk University, Korea)
|
|
| 11:20-11:50 |
Tissue-Based Molecular Workup
Tae Jung Kim (The Catholic University of Korea, Korea)
|
|
|
Luncheon Symposium 7 Lung Cancer  |
Friday, October 31,
11:50-12:20 Room 3 CRYSTAL 3 (3F) |
|
| Chair | Seung Hun Jang (Hallym University, Korea) | |
| 11:50-12:20 |
When Standard isn’t Enough: A New treatment pathway with FLAURA2
Seong Hoon Yoon (Pusan National University, Korea)
|
|